+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2012-10-30Number of Pages: 125

Neuromodulation Devices Market - Global Industry Size, Market Share, Trends, Analysis, And Forecast 2012 - 2018

 

CHAPTER 1 PREFACE

1.1 REPORT DESCRIPTION

1.2 RESEARCH METHODOLOGY

 

CHAPTER 2 EXECUTIVE SUMMARY

 

CHAPTER 3 MARKET OVERVIEW

3.1 MARKET DYNAMICS

      3.1.1 DRIVERS

              3.1.1.1 Aging population inducing chronic diseases such as Parkinson’s and Alzheimer’s disorders

              3.1.1.2 Technological advancements

              3.1.1.3 Rising prevalence of chronic diseases and the presence of unmet medical needs

              3.1.1.4 Add on therapy nature of neuromodulation devices

              3.1.1.5 Increasing demand for minimally invasive surgeries

              3.1.1.6 Rising healthcare related consumer expenditure

              3.1.1.7 Rising instances of external funding to conduct clinical studies

              3.1.1.8 Increasing global prevalence of lifestyle induced illnesses such as depression and obesity

      3.1.2 IMPACT ANALYSIS OF DRIVERS

      3.1.3 RESTRAINTS

              3.1.3.1 Side effects and risks associated with the use of a neuromodulation  device

              3.1.3.2 FDA approvals and other government regulations

                         3.1.3.2.1 Affordable Healthcare for America Act, 2010

              3.1.3.3 Rapidly changing technologies

              3.1.3.4 Availability of alternate treatment procedures

     3.1.4 NEURMODULATION DEVICES MARKET RESTRAINTS IMPACT ANALYSIS

     3.1.5 OPPORTUNITIES

              3.1.5.1 Emerging economies in Asia, Latin America and Eastern European countries

              3.1.5.2 Medical device manufacture outsourcing

              3.1.5.3 Increasing clarity pursuant to the human nervous system

              3.1.5.4 Consolidation opportunities in the healthcare industry

      3.1.6 OPPORTUNITY IMPACT ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET

3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET

      3.2.1 BARGAINING POWER OF SUPPLIERS

      3.2.2 BARGAINING POWER OF BUYERS

      3.2.3 THREAT OF NEW ENTRANTS

      3.2.4 THREAT OF SUBSTITUTES

      3.2.5 COMPETITIVE RIVALRY

3.3 MARKET ATTRACTIVENESS ANALYSIS

      3.3.1 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

      3.3.2 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY

              3.3.2.1 Emerging and Future Market Trends by Technology

 

CHAPTER 4 NEUROMODULATION DEVICES MARKET BY TECHNOLOGY

4.1 OVERVIEW

       4.1.1 GLOBAL NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       4.1.2 GLOBAL NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018

4.2 SPINAL CORD STIMULATION DEVICES

       4.2.1 INTRODUCTION

       4.2.2 MARKET SIZE AND FORECAST

4.3 DEEP BRAIN STIMULATION DEVICES

       4.3.1 INTRODUCTION

       4.3.2 MARKET SIZE AND FORECAST

4.4 SACRAL NERVE STIMULATION DEVICES

       4.4.1 INTRODUCTION

       4.4.2 MARKET SIZE AND FORECAST

4.5 VAGUS NERVE STIMULATION DEVICES

       4.5.1 INTRODUCTION

       4.5.2 MARKET SIZE AND FORECAST

4.6 GASTRIC ELECTRIC STIMULATION DEVICES

       4.6.1 INTRODUCTION

       4.6.2 MARKET SIZE AND FORECAST

 

CHAPTER 5 NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

5.1 OVERVIEW

5.2 NORTH AMERICA

       5.2.1 MARKET OVERVIEW

       5.2.1 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       5.2.2 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

       5.2.3 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET

       5.2.4 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET

       5.2.5 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES MARKET

       5.2.6 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES MARKET

       5.2.7 NORTH AMERICA GASTRIC ELECTRIC STIMULATION DEVICES MARKET

5.3 EUROPE

       5.3.1 MARKET OVERVIEW

       5.3.2 EUROPE NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       5.3.3 EUROPE NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

       5.3.4 EUROPE SPINAL CORD STIMULATION DEVICES MARKET

       5.3.5 EUROPE DEEP BRAIN STIMULATION DEVICES MARKET

       5.3.6 EUROPE SACRAL NERVE STIMULATION DEVICES MARKET

       5.3.7 EUROPE VAGUS NERVE STIMULATION DEVICES MARKET

       5.3.8 EUROPE GASTRIC ELECTRIC STIMULATION DEVICES MARKET

5.4 ASIA PACIFIC

       5.4.1 MARKET OVERVIEW

       5.4.1 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       5.4.2 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018

       5.4.3 ASIA PACIFIC SPINAL CORD STIMULATION DEVICES MARKET

       5.4.4 ASIA PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET

       5.4.5 ASIA PACIFIC SACRAL NERVE STIMULATION DEVICES MARKET

       5.4.6 ASIA PACIFIC VAGUS NERVE STIMULATION DEVICES MARKET

       5.4.7 ASIA PACIFIC GASTRIC ELECTRIC STIMULATION DEVICES MARKET

5.5 REST OF THE WORLD

       5.5.1 MARKET OVERVIEW

       5.5.1 R.O.W NEUROMODULATION DEVICES MARKET BY REVENUE, 2011 – 2018 (USD MILLION)

       5.5.2 ROW NEUROMODULATION DEVICES MARKET BY VOLUME, NO. OF UNITS, 2011 – 2018

       5.5.3 R.O.W SPINAL CORD STIMULATION DEVICES MARKET

       5.5.4 R.O.W DEEP BRAIN STIMULATION DEVICES MARKET

       5.5.5 R.O.W SACRAL NERVE STIMULATION DEVICES MARKET

       5.5.6 R.O.W VAGUS NERVE STIMULATION DEVICES MARKET

       5.5.7 R.O.W GASTRIC ELECTRIC STIMULATION DEVICES MARKET

 

CHAPTER 6 COMPETITIVE LANDSCAPE

6.1 MARKET SHARE BY KEY PLAYERS

6.2 COMPETITIVE STRATEGIES BY KEY PLAYERS

       6.2.1 MARKET LEADERS

       6.2.2 NEW ENTRANTS

 

CHAPTER 7 RECOMMENDATIONS

7.1 MARKET STRATEGY FOR SUCCESS

7.2 BARRIERS TO BE CONSIDERED

 

CHAPTER 8 COMPANY PROFILES

8.1 KEY  PLAYERS

       8.1.1 MEDTRONIC

               8.1.1.1 Company Overview

               8.1.1.2 Business Strategies

               8.1.1.4 Financial Overview

               8.1.1.5 Product Portfolio

               8.1.1.6 Recent Developments

      8.1.2 ST. JUDE MEDICAL

               8.1.2.1 Company Overview

               8.1.2.2 Business Strategies

               8.1.2.4 Financial Overview

               8.1.2.5 Product Portfolio

               8.1.2.6 Recent Developments

      8.1.3 BOSTON SCIENTIFIC

               8.1.3.1 Company Overview

               8.1.3.2 Business Strategies

               8.1.3.4 Financial Overview

               8.1.3.5 Product Portfolio

               8.1.3.6 Recent Developments

      8.1.4 CYBERONICS

               8.1.4.1 Company Overview

               8.1.4.2 Business Strategies

               8.1.4.3 Financial Overview

               8.1.4.4 Product Portfolio

               8.1.4.5 Recent Developments

      8.1.5 NEVRO

               8.1.5.1 Company Overview

               8.1.5.2 Business Strategies

               8.1.5.3 Financial Overview

               8.1.5.4 Product Portfolio

               8.1.5.5 Recent Developments

8.2 NEW ENTRANTS

      8.2.1 NEURONETICS, INC.

               8.2.1.1 Company Overview

               8.2.1.2 Business Strategies

               8.2.1.3 Financial Overview

               8.2.1.4 Product Portfolio

               8.2.1.5 Recent Developments

      8.2.2 UROPLASTY

               8.2.2.1 Company Overview

               8.2.2.2 Business Strategies

               8.2.2.3 Financial Overview

               8.2.2.4 Product Portfolio

               8.2.2.5 Recent Developments

LIST OF FIGURES

 

FIG. 1 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

FIG. 2 HEALTHCARE RELATED CONSUMER EXPENDITURE IN JAPAN, U.S., GERMANY AND CANADA, 2008 TO 2010 (USD  MILLION)

FIG. 3 HEALTHCARE RELATED CONSUMER EXPENDITURE IN BRAZIL, INDIA AND CHINA, 2008 TO 2010 (USD  MILLION)

FIG. 4 OPPORTUNITY IMPACT ANALYSIS FOR THE NEUROMODULATION DEVICES  MARKET

FIG. 5 PORTER’S FIVE FORCES ANALYSIS FOR THE NEUROMODULATION DEVICES MARKET

FIG. 6 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY GEOGRAPHY

FIG. 7 MARKET ATTRACTIVENESS ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY

FIG. 8 COMPARITIVE ANALYSIS OF NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 9 GLOBAL NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 10 GLOBAL SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 11 GLOBAL DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 12 GLOBAL SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 13 GLOBAL VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 14 GLOBAL GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 15 COMPARATIVE ANALYSIS OF THE NEUROMODULATION DEVICES MARKET BY GEOGRAPHY, 2011 & 2018 (%)

FIG. 16 COMPARATIVE ANALYSIS OF THE NORTH AMERICAN NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 17 NORTH AMERICA NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 18 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 19 NORTH AMERICA DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 20 NORTH AMERICA SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 21 NORTH AMERICA VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 22 NORTH AMERICA GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 23 COMPARATIVE ANALYSIS OF THE EUROPEAN NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 24 EUROPE NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 25 EUROPE SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 26 EUROPE DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 27 EUROPE SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 28 EUROPE VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 29 EUROPE GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 30 COMPARATIVE ANALYSIS OF THE ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 31 ASIA PACIFIC NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 32 ASIA PACIFIC SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 33 ASIA PACIFIC DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 34 ASIA PACIFIC SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 35 ASIA PACIFIC VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 36 ASIA PACIFIC GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 37 COMPARITIVE ANALYSIS OF THE R.O.W NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 & 2018 (%)

FIG. 38 R.O.W NEUROMODULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 39 R.O.W SPINAL CORD STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 40 R.O.W DEEP BRAIN STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 41 R.O.W SACRAL NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 42 R.O.W VAGUS NERVE STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 43 R.O.W GASTRIC ELECTRIC STIMULATION DEVICES MARKET, 2011 – 2018 (USD MILLION)

FIG. 44 MARKET SHARE BY KEY PLAYERS, 2011 (%)

FIG. 45 SWOT ANALYSIS OF MEDTRONIC

FIG. 46 ANNUAL REVENUE (USD MILLION) OF MEDTRONIC, 2008 - 2011

FIG. 47 SWOT ANALYSIS OF ST. JUDE MEDICAL

FIG. 48 ANNUAL REVENUE (USD MILLION) OF ST. JUDE MEDICAL, 2008 - 2011

FIG. 49 SWOT ANALYSIS OF BOSTON SCIENTIFIC GROUP

FIG. 50 ANNUAL REVENUE (USD MILLION) OF BOSTON SCIENTIFIC GROUP, 2008 - 2011

FIG. 51 ANNUAL REVENUE (USD MILLION) OF CYBERONICS, 2008 - 2011

FIG. 52 ANNUAL REVENUE (USD MILLION) OF UROPLASTY, 2008 - 2011

TABLE OF CONTENTS

 

TABLE 1 GLOBAL NEUROMODULATION DEVICES MARKET BY TECHNOLOGY, 2011 – 2018 (USD MILLION)

TABLE 2 IMPACT ANALYSIS OF DRIVERS

TABLE 3 IMPACT ANALYSIS OF RESTRAINTS

TABLE 4 EMERGING AND FUTURE MARKET TRENDS BY TECHNOLOGY

TABLE 5 GLOBAL NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

TABLE 6 PRODUCTS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE SPINAL CORD STIMULATION DEVICES MARKET

TABLE 7 GLOBAL SPINAL CORD STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 8 GLOBAL SPINAL CORD STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 9 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE DEEP BRAIN STIMULATION DEVICES MARKET

TABLE 10 GLOBAL DEEP BRAIN STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 11 GLOBAL DEEP BRAIN STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 12 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE SACRAL NERVE STIMULATION DEVICES MARKET

TABLE 13 GLOBAL SACRAL NERVE STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 14 GLOBAL SACRAL NERVE STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 15 PRODUCT STATUS BY KEY PLAYERS AND THE APPROVAL STATUS CONCERNING THE VAGUS NERVE STIMULATION DEVICES MARKET

TABLE 16 GLOBAL VAGUS NERVE STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 17 GLOBAL VAGUS NERVE STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 18 GLOBAL GASTRIC ELCTRIC STIMULATION  DEVICES MARKET REVENUE BY GEOGRAPHY, 2011 – 2018 (USD MILLION)

TABLE 19 GLOBAL GASTRIC ELECTRIC STIMULATION  DEVICES MARKET VOLUME BY GEOGRAPHY, 2011 – 2018 (NUMBER OF UNITS)

TABLE 20 NORTH AMERICA NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

TABLE 21 NORTH AMERICA NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

TABLE 22 EUROPE NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

TABLE 23 EUROPE NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

TABLE 24 ASIA PACIFIC NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

TABLE 25 ASIA PACIFIC NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

TABLE 26 R.O.W NEUROMODULATION DEVICES MARKET REVENUE, 2011 – 2018 (USD MILLION)

TABLE 27 R.O.W NEUROMODULATION DEVICES MARKET BY VOLUME, 2011 – 2018 (NUMBER OF UNITS)

Neuromodulation devices are used to carry out a process by which a neuron uses one or more neurotransmitters to regulate other populations of neurons. Neuromodulation is a physiological process by which nervous activity is regulated by controlling the physiological levels of several classes of neurotransmitters. One of the fastest growing sectors of the medical devices market, the neuromodulation devices market is estimated to reach a value of US$7.1 bn by 2018, expanding at a CAGR of 14.4% in the period from 2012 to 2018.

Neuromodulation devices are used to provide relief to a patient through modulation or alteration of nervous system function. Neuromodulation functions by stimulating the nerves to produce responses that are natural or by the application of small doses of medicines directly at the site where required. Due to an increase in the adoption of minimally invasive treatment options and medical tourism, the market for neuromodulation devices is expected to grow in the next decade. 

The report addresses questions related to the neuromodulation devices market such as the details about the various segments and sub-segments of the neuromodulation devices market, the current and future trends, the growth drivers, and the factors inhibiting the market. Collated by expert market analysts, the study can be used for expansion, competition monitoring, and for investing in the neuromodulation devices market. 

Overview of the Neuromodulation Devices Market

The global neuromodulation devices market is segmented on the basis of technology, application, and geography. On the basis of geography, the global neuromodulation devices market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Out of these regions, North America dominated the market in 2011, accounting for 65% of the global neuromodulation devices market, and being valued at US$1.8 bn. Asia Pacific is expected to expand at a CAGR of over 15% between 2012 and 2018, owing to the rising demand for neuromodulation devices from developing nations. 

The major growth drivers of the global neuromodulation devices market include the rising prevalence of chronic diseases, rising geriatric population, rising vulnerability to acquire diseases such as Parkinson’s and Alzheimer’s, and technological advancements in neuromodulation devices, making them effective as an add-on therapy. The rising prevalence of lifestyle-induced illnesses such as obesity or depression, increase in the demand for minimally invasive surgeries, increasing consumer expenditure, and an increase in the funds to conduct studies are driving the global market for neuromodulation devices. 

The market’s growth is likely to be inhibited by the changing technological landscape, the availability of alternate treatment procedures, and the side effects and risks associated with the use of neuromodulation devices. Other restraining factors include getting FDA approvals and stringent government regulations that may hamper the market for the forecast period. 

Key Players in the Neuromodulation Devices Market:

The leading players in the neuromodulation devices market that have been profiled and analyzed in the report are: Uroplasty, Codman and Shurtleff, Cervel Neurotech Inc., IntraPace, Nevro , Medtronic, Boston Scientific Group, Integra, St. Jude Medical, Neuronetics Inc., and Cyberonics.
 
Segmentation by Technology Type:

  • Spinal cord stimulation medical devices
  • Deep brain stimulation devices
  • Sacral nerve stimulation devices
  • Vagus nerve stimulation devices
  • Gastric electric stimulation devices. 

Segmentation by Application Area:

  • Medtronic’s Spinal Cord and Deep Brain Neurostimulation Systems
  • St. Jude Medical’s Eon Mini Neurostimulator System
  • Boston Scientific’s Precision Spinal Cord Stimulation System
  • Nevro’s Senza System for Spinal Cord Stimulation
  • Cyberonics’ VNS Therapy System
  • Codman & Shurtleff’s Medstream System
  • Medtronic’s Enterra Therapy System
  • IntraPace’s abiliti system.

Segmentation by Geography:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW). 

This report gives you access to decisive data such as:

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements 
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments

 

Neuromodulation is one of the fastest growing sectors in the medical devices market. Neuromodulation devices provide symptomatic relief through alteration, or modulation of nerve system function. Neuromodulation functions either by stimulating nerves to produce a natural biological response or by applying small doses of medicines directly to the site of action. The neuromodulation devices market is growing rapidly due to increase in the ageing population resulting in increased demand for newer treatment options for age related diseases. 

 

This market is expected to benefit from the rise in demand for non-invasive treatment options. Advancement in technology and increased knowledge in neurophysiology offers vast potential opportunities in treatment, influencing stupendous growth of the neuromodulation devices market. Neuromodulation market addresses the huge patient population in epilepsy, anxiety disorders, stroke, depression, Parkinson’s disease, and others. With this stupendous growth, neuromodulation market is expected to become as large as the cardiac devices market.

 

Market Segmentation

  • Deep Brain Stimulation (DBS)
  • Transcranial Magnetic Stimulation (TMS)
  • Spinal Cord Stimulation (SCS)
  • Vagus Nerve Stimulation (VNS)
  • Peripheral Stimulation

This research report analyzes this market based on its market segments and major geographies. It includes a comprehensive study of the ongoing market trends, industry growth drivers, restraints, market structure, and market projections for the coming years. The report also includes an analysis of the technological developments in the neuromodulation devices market, Porter’s five force model analysis, and company profiles of the top industry players. It provides a review of the micro and macro factors significant from the point of view of the existing market players and new entrants with value chain analysis. 

 

Major geographies analyzed under this report are North America, Europe, Asia-Pacific, and the Rest of the World.

 

Some of the major players dominating the market of neuromodulation devices are Medtronic, St. Jude Medical, Boston Scientific, Cyberonics, IntraPace, Nevro, Johnson & Johnson, Codman, Integra, and others. 


 
 
Back To Top